|
|
| Address | 1A-B rue Thomas Edison L-1445 Strassen Luxembourg |
|---|---|
| Platforms | ATMP & Biological, Biomarkers, Vaccines |
| Tags | Genomics, Immunity, Infection, Luxembourg, Luxembourg Institute of Health, Oncology, Population Health |
The Luxembourg Institute of Health is a public biomedical research organisation. Striving for excellence, its researchers, by their creativity, enthusiasm and commitment, generate knowledge on disease mechanisms and contribute to the development of new diagnostics, innovative therapies and clinical applications that impact the healthcare of Luxembourgish and European citizens.
At the forefront of biomedical sciences, the Luxembourg Institute of Health is deeply involved in implementing national and international research programs in personalized medicine. It acts as a catalyst for promoting research collaborations with healthcare providers, hospitals and other public and private biomedical organisations. To create economic and societal value, it purposes the translation of its scientific discoveries and technological developments. As the first supplier of public health information in Luxembourg, it also enables public authorities to make decisions based on scientific data and to communicate validated data to international institutions.
LIH is comitted to the investigation of Translational Health, Preventive Medicine and Digital Health.
LIH has the following translational structures and platforms:
The Luxembourg Institute of Health hosts a large number of trainees, Master students and PhD candidates, affiliated to the University of Luxembourg or to foreign partner universities, as well as postdoctoral scientists specialising themselves in a given research domain. Modern infrastructure, state-of-the-art technologies and a stimulating work environment, guaranteeing quality supervision and training, are provided to these young scientists starting their career.
